Search results
Results from the WOW.Com Content Network
Lowe was one of the first people to blog from inside the pharmaceutical industry, with the approval of his supervisor and the company legal department, [5] and one of the first science bloggers. [6] By 2006, his blog had between 3,000 and 4,000 visitors per day during the workweek; he covered business matters, trends and issues in medicinal ...
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, [1] develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.
Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. [3]
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. [2] The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York.The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders.
In September 2011, Takeda acquired Nycomed for €9.6 billion. [18]In May 2012, Takeda purchased Brazilian pharmaceutical company Multilab for R$540 million. [19] In June, Takeda announced it would acquire URL Pharma, then run by the founder's son Richard Roberts, for US$800 million.
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings.